Metraipolis › archive › dc_f970c376e805

Levodopa/carbidopa/entacapone versus levodopa/benserazide plus pramipexole in Chinese patients with Parkinson's disease experiencing wearing off — Europe PMC PMID:41346381

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41346381
DOI
10.3389/fneur.2025.1682614
License (as archived)
solo-consultazione
Archived
2026-11-08T10:16:14.093Z
SHA-256 of the archived text
04705796b147cc087f118382e581b11cca0ef0728f9c5667ccfa353c8be7de2d
Stable URL of this page
https://metraipolis.com/documento/dc_f970c376e805

How to cite

Levodopa/carbidopa/entacapone versus levodopa/benserazide plus pramipexole in Chinese patients with Parkinson's disease experiencing wearing off — Europe PMC PMID:41346381 — Europe PMC (en), https://europepmc.org/article/MED/41346381 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f970c376e805 (Metraipolis archive dc_f970c376e805, sha256 04705796b147cc087f118382e581b11cca0ef0728f9c5667ccfa353c8be7de2d)
BibTeX
@misc{dcf970c376e805,
  title = {Levodopa/carbidopa/entacapone versus levodopa/benserazide plus pramipexole in Chinese patients with Parkinson's disease experiencing wearing off — Europe PMC PMID:41346381},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41346381},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f970c376e805; sha256 04705796b147cc087f118382e581b11cca0ef0728f9c5667ccfa353c8be7de2d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41346381. Agents can read the archived copy with the MCP tool read_document.